Join Matindale-Hubbell Connected



Search Results (2682)

  
Documents on biotech life sciences
 

View Page: Prev  1  2  3  4  5  6  7  8  9  10  Next  >>
Show: results per page
Sort by:
Sponsored Results

HTMLDNA Samples
Tamara Bogosian, Paul A. Cappitelli, G. Ross Trindle; Best Best & Krieger LLP;
Legal Alert/Article
March 25, 2014, previously published on March 21, 2014
Overview: The Ninth Circuit Court of Appeals recently upheld a California law requiring that all persons arrested for, or charged with, a felony or attempted felony submit DNA samples for inclusion in law enforcement databases. The constitutional challenge was brought by a class of individuals that...

 

HTMLITC Institutes Investigation (337-TA-911) Regarding Certain Lithium Silicate Materials
Alexander B. Englehart, Eric W. Schweibenz; Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P.;
Legal Alert/Article
March 25, 2014, previously published on March 24, 2014
On March 21, 2014, the U.S. International Trade Commission issued a press release announcing their vote to institute an investigation of Certain Lithium Silicate Materials and Products Containing the Same (Inv. No. 337-TA-911).

 

HTMLALJ Bullock Denies Summary Determination Of No Violation Based On Induced Infringement In Certain Antivenom Compositions (337-TA-903)
Alexander B. Englehart, Eric W. Schweibenz; Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P.;
Legal Alert/Article
March 25, 2014, previously published on March 19, 2014
On March 14, 2014, Chief ALJ Charles E. Bullock issued Order No. 16 in Certain Antivenom Compositions and Products Containing the Same (Inv. No. 337-TA-903). In the Order, ALJ Bullock denied Respondents Laboratorios Silanes S.A. de C.V. and Instituto Bioclan S.A. de C.V.’s (collectively,...

 

HTMLALJ Bullock Terminates Investigation as To Veteria Labs and BioVeteria Life Sciences in Certain Antivenom Compositions (337-TA-903)
Eric W. Schweibenz; Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P.;
Legal Alert/Article
March 20, 2014, previously published on March 18, 2014
On March 11, 2014, Chief ALJ Charles E. Bullock issued Order No. 14 in Certain Antivenom Compositions and Products Containing the Same (Inv. No. 337-TA-903).

 

HTMLALJ Bullock Denies Summary Determination Motion in Certain Antivenom Compositions (337-TA-903)
Eric W. Schweibenz; Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P.;
Legal Alert/Article
March 20, 2014, previously published on March 18, 2014
On March 11, 2014, Chief ALJ Charles E. Bullock issued Order No. 12 in Certain Antivenom Compositions and Products Containing the Same (Inv. No. 337-TA-903).

 

HTMLThousands Injured From Transvaginal Mesh Device, Litigation Continues
Brayton Purcell LLP;
Legal Alert/Article
March 17, 2014
Surgical mesh was first approved by the FDA in the 1950s to repair hernias. In the 1990s, the product was expanded to treat pelvic organ prolapsed and stress urinary incontinence conditions, particularly for women post childbirth. However, thousands of women have suffered injuries from transvaginal...

 

HTMLALJ Gildea Rules On Motion To Compel Deposition In Advisory Opinion Proceeding In Certain Sleep-Disordered Breathing Treatment Systems (337-TA-879)
Alexander B. Englehart, Eric W. Schweibenz; Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P.;
Legal Alert/Article
March 17, 2014, previously published on March 13, 2014
On March 10, 2014, ALJ E. James Gildea issued the public version of Order No. 17 (dated February 27, 2014) in Certain Sleep-Disordered Breathing Treatment Systems and Components Thereof (Inv. No. 337-TA-879). In the Order, ALJ Gildea granted-in-part Complainants ResMed Inc., ResMed Ltd., and ResMed...

 

HTMLUSPTO Issues Guidance for Examining Process Patents
Antoinette F. Konski; Foley & Lardner LLP;
Legal Alert/Article
March 11, 2014, previously published on March 7, 2014
On March 4th, 2014, the U.S. Patent and Trademark Office (USPTO) issued “2014 Procedures For Subject Matter Eligibility Analysis Of Claims Reciting Or Involving Laws of Nature/Natural Principles, Natural Phenomena, And/Or Natural Products“ Guidance, advising examiners and the public of...

 

Adobe PDFDoes Myriad Alter the Patentability of Natural Products?
Leslie Kushner, Robert S. Schwartz; Fitzpatrick, Cella, Harper & Scinto;
Legal Alert/Article
March 10, 2014, previously published on March 2014
Whether the US Supreme Court’s June 13 2013 ruling in Association for Molecular Pathology v Myriad Genetics, Inc, 133 S Ct 2107 (2013) — that “[a] naturally occurring DNA segment is a product of nature and not patent eligible merely because it has been isolated” — is...

 

HTMLUSPTO to Apply Myriad Beyond Isolated DNA
Antoinette F. Konski; Foley & Lardner LLP;
Legal Alert/Article
March 10, 2014, previously published on March 5, 2014
Today, the United States Patent and Trademark Office (“USPTO”) issued a Guidance, advising examiners and the public of the factors for determining whether an invention satisfies the U.S. Supreme Court’s interpretation of 35 U.S.C. §101, as applied to patent-eligibility. See...

 


View Page: Prev  1  2  3  4  5  6  7  8  9  10  Next  >>